Summary & Overview
HCPCS J1612: Injection, Glucagon (Gvoke), 0.01 mg
HCPCS Level II code J1612 denotes the injection of glucagon (Gvoke), 0.01 mg, used as an acute rescue medication for severe hypoglycemia. This code identifies the drug product and its specific microdose formulation, facilitating drug-specific billing and tracking across outpatient and emergency care settings. Nationwide, accurate coding for rescue glucagon is important for claims processing, medication utilization monitoring, and policy alignment for coverage of emergent diabetes care.
Key payers addressed in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise briefing on clinical context and expected sites of service for J1612, alongside payer coverage framing and common billing modifiers. The publication also summarizes typical documentation elements associated with administering an injectable hypoglycemia rescue agent and highlights areas where national billing practice and policy updates can affect reimbursement and access.
This resource is written for a national audience of billing professionals, clinicians, and policy analysts seeking clarity on the clinical meaning, billing context, and payer landscape for HCPCS Level II code J1612. Data not available in the input will be noted where relevant in detailed sections.
Billing Code Overview
HCPCS Level II code J1612 represents an injection of glucagon (Gvoke) in a microdose of 0.01 mg. The service is an administration of a glucagon rescue agent, intended for acute management of severe hypoglycemia when a patient is unable to safely ingest carbohydrates.
-
Service type: Medication administration (injectable rescue therapy)
-
Typical site of service: Outpatient settings including emergency departments, urgent care clinics, outpatient infusion or injection clinics, and other ambulatory care locations where acute hypoglycemia may be treated.
Clinical & Coding Specifications
Clinical Context
A patient with insulin-treated diabetes experiences severe hypoglycemia with altered consciousness or inability to safely take oral carbohydrates in the outpatient, clinic, emergency department, or prehospital setting. A caregiver, emergency medical technician, or clinician prepares and administers a single-use J1612 injection (glucagon, Gvoke, 0.01 mg increment) for rapid reversal of hypoglycemia. The typical workflow: recognition of hypoglycemia (symptoms, point-of-care glucose), indication for glucagon when oral/IV dextrose is not feasible, preparation and subcutaneous or intramuscular administration of the prefilled syringe or autoinjector, monitoring for clinical response and airway protection, and documentation of vital signs, blood glucose response, lot number, and time of administration. Subsequent care includes reassessment of blood glucose, provision of oral carbohydrates when safe, observation for recurrent hypoglycemia, and disposition decisions (discharge home with caregiver education vs. transfer to higher level of care). Typical sites of service include outpatient clinics, urgent care centers, emergency departments, patient homes, and ambulance/EMS settings.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier | Use when no special circumstance applies to the service |